Vitiligo – Epidemiology – Middle East & Africa

DRG Epidemiology’s coverage of vitiligo comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the diagnosed prevalence of vitiligo for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.

DRG Epidemiology’s vitiligo forecast will answer the following questions:

  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of vitiligo over the forecast period?
  • Of all people diagnosed with vitiligo, how many cases are segmental or nonsegmental vitiligo?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

DRG Epidemiology provides at least ten years of forecast data for the following vitiligo subpopulations:

  • Diagnosed prevalent cases.
  • Diagnosed prevalent cases by subtype.

Note: Coverage may vary by country.

Table of contents

  • Vitiligo - Epidemiology - Middle East & Africa
    • Epidemiology Data
    • Methods
      • Diagnosed Prevalent Cases
      • Diagnosed Prevalent Cases by Subtype
    • Reference Materials
      • Bibliography

Login to access report